Recombinant interferon alfa-2b/Diphenhydramine

重组干扰素α-2b/苯海拉明

Report date: 2024/05/29 14:22:20

Base Information

Drug NameRecombinant interferon alfa-2b/Diphenhydramine
Drug Alias NameDiphenhydramine/Recombinant interferon alfa-2b苯海拉明/干扰素α-2bOftalmoferon
ClassificationBiologics
Mechanisms of ActionHistamine H1 receptor inverse agonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsConjunctivitis
Global Approved IndicationsConjunctivitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2008/10/01
Country/TerritoryRussian Federation
CombinationsYes Diphenhydramine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFirn M Zao
China Registration ClassN/A

Develop Information

Active CompaniesFirn M Zao
Inactive CompaniesN/A
Active IndicationsConjunctivitis
Inactive IndicationsN/A

Other Information

ATC CodeR06AA52
Related LinksN/A